clinical trial · NCT07018635
A Study to Assess the Effect of Itraconazole, Rifampin, and Acid-Reducing Agents on INCB161734 Pharmacokinetics When Administered Orally in Healthy Participants
Healthy ParticipantsINCB161734ItraconazoleRifampinEsomeprazoleFamotidine
brief summary
This study is conducted to assess the effect of itraconazole, rifampin, and acid-reducing agents on INCB161734 pharmacokinetics when administered orally in healthy participants.
started
Jul 16, 2025
primary completion
Sep 29, 2025
completion
Sep 29, 2025
last updated
Nov 26, 2025
official title
An Open-Label Study to Assess the Effect of Itraconazole, Rifampin, and Acid-Reducing Agents on INCB161734 Pharmacokinetics When Administered Orally in Healthy Participants
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol